单细胞t细胞受体测序检测无症状COVID-19患者TCR谱

IF 2.1 4区 医学 Q3 HEMATOLOGY
Han Bai , Junpeng Ma , Weikang Mao , Xuan Zhang , Yijun Nie , Jingcan Hao , Xiaorui Wang , Hongyu Qin , Qiqi Zeng , Fang Hu , Xin Qi , Xiaobei Chen , Dong Li , Binghong Zhang , Bingyin Shi , Chengsheng Zhang
{"title":"单细胞t细胞受体测序检测无症状COVID-19患者TCR谱","authors":"Han Bai ,&nbsp;Junpeng Ma ,&nbsp;Weikang Mao ,&nbsp;Xuan Zhang ,&nbsp;Yijun Nie ,&nbsp;Jingcan Hao ,&nbsp;Xiaorui Wang ,&nbsp;Hongyu Qin ,&nbsp;Qiqi Zeng ,&nbsp;Fang Hu ,&nbsp;Xin Qi ,&nbsp;Xiaobei Chen ,&nbsp;Dong Li ,&nbsp;Binghong Zhang ,&nbsp;Bingyin Shi ,&nbsp;Chengsheng Zhang","doi":"10.1016/j.bcmd.2022.102678","DOIUrl":null,"url":null,"abstract":"<div><p>The T cell-mediated immune responses associated with asymptomatic infection (AS) of SARS-CoV-2 remain largely unknown. The diversity of T-cell receptor (TCR) repertoire is essential for generating effective immunity against viral infections in T cell response. Here, we performed the single-cell TCR sequencing of the PBMC samples from five AS subjects, 33 symptomatic COVID-19 patients and eleven healthy controls to investigate the size and the diversity of TCR repertoire. We subsequently analyzed the TCR repertoire diversity, the V and J gene segment deference, and the dominant combination of αβ VJ gene pairing among these three study groups. Notably, we revealed significant TCR preference in the AS group, including the skewed usage of TRAV1-2-J33-TRBV6-4-J2-2 and TRAV1-2-J33-TRBV6-1-J2-3. Our findings may shed new light on understanding the immunopathogenesis of COVID-19 and help identify optimal TCRs for development of novel therapeutic strategies against SARS-CoV-2 infection.</p></div>","PeriodicalId":8972,"journal":{"name":"Blood Cells Molecules and Diseases","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162783/pdf/","citationCount":"3","resultStr":"{\"title\":\"Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing\",\"authors\":\"Han Bai ,&nbsp;Junpeng Ma ,&nbsp;Weikang Mao ,&nbsp;Xuan Zhang ,&nbsp;Yijun Nie ,&nbsp;Jingcan Hao ,&nbsp;Xiaorui Wang ,&nbsp;Hongyu Qin ,&nbsp;Qiqi Zeng ,&nbsp;Fang Hu ,&nbsp;Xin Qi ,&nbsp;Xiaobei Chen ,&nbsp;Dong Li ,&nbsp;Binghong Zhang ,&nbsp;Bingyin Shi ,&nbsp;Chengsheng Zhang\",\"doi\":\"10.1016/j.bcmd.2022.102678\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The T cell-mediated immune responses associated with asymptomatic infection (AS) of SARS-CoV-2 remain largely unknown. The diversity of T-cell receptor (TCR) repertoire is essential for generating effective immunity against viral infections in T cell response. Here, we performed the single-cell TCR sequencing of the PBMC samples from five AS subjects, 33 symptomatic COVID-19 patients and eleven healthy controls to investigate the size and the diversity of TCR repertoire. We subsequently analyzed the TCR repertoire diversity, the V and J gene segment deference, and the dominant combination of αβ VJ gene pairing among these three study groups. Notably, we revealed significant TCR preference in the AS group, including the skewed usage of TRAV1-2-J33-TRBV6-4-J2-2 and TRAV1-2-J33-TRBV6-1-J2-3. Our findings may shed new light on understanding the immunopathogenesis of COVID-19 and help identify optimal TCRs for development of novel therapeutic strategies against SARS-CoV-2 infection.</p></div>\",\"PeriodicalId\":8972,\"journal\":{\"name\":\"Blood Cells Molecules and Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162783/pdf/\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Cells Molecules and Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1079979622000353\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Cells Molecules and Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1079979622000353","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 3

摘要

与SARS-CoV-2无症状感染(AS)相关的T细胞介导的免疫反应在很大程度上仍然未知。在T细胞应答中,T细胞受体(TCR)库的多样性对于产生有效的抗病毒感染免疫至关重要。在这里,我们对5名AS受试者、33名症状性COVID-19患者和11名健康对照者的PBMC样本进行了单细胞TCR测序,以研究TCR库的大小和多样性。随后,我们分析了三个研究组的TCR库多样性、V和J基因片段的差异以及αβ VJ基因配对的优势组合。值得注意的是,我们揭示了AS组显著的TCR偏好,包括TRAV1-2-J33-TRBV6-4-J2-2和TRAV1-2-J33-TRBV6-1-J2-3的倾斜使用。我们的发现可能为理解COVID-19的免疫发病机制提供新的思路,并有助于确定最佳的tcr,以开发针对SARS-CoV-2感染的新治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing

Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing

Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing

Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing

The T cell-mediated immune responses associated with asymptomatic infection (AS) of SARS-CoV-2 remain largely unknown. The diversity of T-cell receptor (TCR) repertoire is essential for generating effective immunity against viral infections in T cell response. Here, we performed the single-cell TCR sequencing of the PBMC samples from five AS subjects, 33 symptomatic COVID-19 patients and eleven healthy controls to investigate the size and the diversity of TCR repertoire. We subsequently analyzed the TCR repertoire diversity, the V and J gene segment deference, and the dominant combination of αβ VJ gene pairing among these three study groups. Notably, we revealed significant TCR preference in the AS group, including the skewed usage of TRAV1-2-J33-TRBV6-4-J2-2 and TRAV1-2-J33-TRBV6-1-J2-3. Our findings may shed new light on understanding the immunopathogenesis of COVID-19 and help identify optimal TCRs for development of novel therapeutic strategies against SARS-CoV-2 infection.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.90
自引率
0.00%
发文量
42
审稿时长
14 days
期刊介绍: Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信